Follow-up survey following the completion of 'A open-label, randomized controlled study of adjuvant therapy with TAP-144-SR (3M) in premenopausal breast cancer patients'
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2015
At a glance
- Drugs Leuprorelin (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jan 2014 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan.
- 04 Oct 2011 New trial record